Note: This document has been translated from the Japanese original for reference purpose only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
February 5, 2026
Trade name: Noevir Holdings Co., Ltd.
Listing: Tokyo Stock Exchange, Prime Market (Securities Code: 4928) URL: https://www.noevirholdings.co.jp/
Representative: Takashi Okura, President and CEO Contact: Junya Baba, General Manager, Accounting
Tel. +81-78-303-5121
Date of commencement of dividend payments: -
Supplemental materials for the financial results prepared: None Results briefing for the reporting period held: None
(Amounts under one million yen have been rounded down)
Operating results for the first three months of the fiscal year ending September 30, 2026 (October 1, 2025 to December 31, 2025)
Consolidated operating results
(Millions of yen; percentage figures denote year-on-year change)
Net sales
Operating income
Ordinary income
Net income attributable to owners of the parent
Three months ended December 31, 2025
15,466
(7.9)%
2,251
(29.0)%
2,417
(26.2)%
1,321
35.7%
Three months ended December 31, 2024
16,802
1.1%
3,173
(10.2)%
3,274
(8.4)%
973
(3.2)%
Note: Comprehensive income:
Three months ended December 31, 2025: 1,669 million yen [30.8%]
Three months ended December 31, 2024: 1,276 million yen [20.6%]
EPS (Yen)
Diluted EPS (Yen)
Three months ended December 31, 2025
38.70
-
Three months ended December 31, 2024
28.51
-
Consolidated financial position
(Millions of yen)
Total assets
Net assets
Equity ratio (%)
As of December 31, 2025
70,427
48,022
67.4
As of September 30, 2025
76,492
54,209
70.3
[Reference] Equity:
As of December 31, 2025: 47,468 million yen
As of September 30, 2025: 53,767 million yen
Cash dividends
(Yen)
Annual dividends
1st quarter
2nd quarter
3rd quarter
Year-end
Total
Fiscal year ended September 30, 2025
-
0.00
-
230.00
230.00
Fiscal year ended September 30, 2026
-
Fiscal year ending September 30, 2026 (forecast)
0.00
-
230.00
230.00
Note: Revisions from the most recently announced dividend forecast: None
Consolidated earnings forecasts for the fiscal year ending September 30, 2026 (October 1, 2025 to September 30, 2026)
(Millions of yen; percentage figures denote year-on-year change)
Net sales | Operating | income | Ordinary | income | Net income attributable to owners of the parent | EPS (Yen) | |||
Full year | 65,000 | 0.4% | 11,400 | 2.9% | 11,800 | 0.2% | 8,200 | 2.1% | 240.07 |
Note: Revisions from the most recently announced consolidated earnings forecast: None
* Notes
Significant changes in the scope of consolidation during the period: None
Special accounting treatment for preparation of quarterly consolidated financial statements: None
Changes in accounting policies, changes in accounting estimates, and restatement
Changes associated with revision in accounting standards: None
Other changes: None
Changes in accounting estimates: None
Restatement: None
Shares outstanding (common stock)
Shares outstanding (including treasury stock) As of December 31, 2025: 34,156,623
As of September 30, 2025: 34,156,623
Treasury shares outstanding
As of December 31, 2025: 416
As of September 30, 2025: 416
Average shares outstanding over quarter
Three months ended December 31, 2025: 34,156,207
Three months ended December 31, 2024: 34,156,207
Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: None
Explanation regarding the appropriate use of business performance forecasts
Forward-looking statements included in these materials, such as forecasts of business performance, are based on information known to the Company's management as of the time of writing, and reflect judgments believed to be reasonable on the basis of that information. There is, therefore, a possibility that actual business performance figures will differ substantially from our forecasts as a result of changes in the economic situation and other unforeseeable factors. Please refer to "(3) Estimates and forecasts pertaining to future plans and business results" under "1. Operating results and financial information" on page 5 of the Attached Material.
Contents of the Attached Material
Operating results and financial information 4
Operating results for the first three months of the fiscal year ending September 30, 2026 4
Financial position as of December 31, 2025 5
Estimates and forecasts pertaining to future plans and business results 5
Quarterly consolidated financial statements and notes 6
Quarterly consolidated balance sheets 6
Quarterly consolidated statements of income and comprehensive income 8
Notes to the quarterly consolidated financial statements 10
(Note on assumptions for going concern) 10
(Note on significant changes in the amount of shareholders' equity) 10
(Note on statement of cash flows) 10
(Note on segment information) 10
-
Operating results and financial information
Operating results for the first three months of the fiscal year ending September 30, 2026 Consolidated operating results for the first three months of the fiscal year ending September 30, 2026 (October 1, 2025 to December 31, 2025)
Three months ended
December 31, 2024
Three months ended
December 31, 2025
Change (Millions of yen)
Change (%)
Net sales (Millions of yen)
% of Total
Net sales (Millions of yen)
% of Total
Net sales
16,802
100.0
15,466
100.0
(1,335)
(7.9)
Cosmetics
13,547
80.6
12,279
79.4
(1,268)
(9.4)
Pharmaceuticals & Health Food
2,953
17.6
2,878
18.6
(74)
(2.5)
Other
300
1.8
308
2.0
8
2.7
Three months ended December 31, 2024
Three months ended December 31, 2025
Change (Millions of yen)
Change (%)
Amount (Millions of yen)
% of Net sales
Amount (Millions of yen)
% of Net sales
Operating income
3,173
18.9
2,251
14.6
(921)
(29.0)
Ordinary income
3,274
19.5
2,417
15.6
(857)
(26.2)
Net income attributable to owners of the parent
973
5.8
1,321
8.5
348
35.7
During the first three months of fiscal 2026 (October 1, 2025 to December 31, 2025), economic trends remained uncertain, although some signs of gradual recovery were observed.
In this environment, the Company is working to realize the concept of its medium- to long-term strategy: "Realizing steady corporate growth by securing sustainability in every Group business segment."
As a result, net sales for the first three months of fiscal 2026 came to 15,466 million yen (down 7.9% year on year), operating income was 2,251 million yen (down 29.0%), ordinary income was 2,417 million yen (down 26.2%), and net income attributable to owners of the parent came to 1,321 million yen (up 35.7%).
In the Cosmetics segment, net sales totaled 12,279 million yen (down 9.4% year on year), and segment income came to 2,525 million yen (down 28.6%).
In the Pharmaceuticals & Health Food segment, net sales totaled 2,878 million yen (down 2.5% year on year), and segment income came to 372 million yen (up 49.9%).
In the Other segment, net sales totaled 308 million yen (up 2.7% year on year), and segment income came to 10 million yen (up 10.3%).
Financial position as of December 31, 2025
Total assets as of December 31, 2025 stood at 70,427 million yen, a decrease of 6,065 million yen from the previous fiscal year-end. This was mainly due to decreases in cash and cash deposits of 14,438 million yen and notes and accounts receivable of 1,859 million yen, while there was an increase in securities of 9,995 million yen.
Total liabilities came to 22,404 million yen, an increase of 120 million yen from the previous fiscal year-end. This mainly reflected an increase in other accounts payable of 479 million yen, while there was a decrease in income tax payable of 350 million yen.
Net assets came to 48,022 million yen, a decrease of 6,186 million yen from the previous fiscal year-end.
This was primarily attributable to a decrease in retained earnings of 6,533 million yen, due to the payment of 7,855 million yen in dividends at the previous fiscal year-end, which was partly offset by net income attributable to owners of the parent of 1,321 million yen.
As a result, the equity ratio stood at 67.4%.
Estimates and forecasts pertaining to future plans and business results
The consolidated business performance forecasts for the full year ending September 30, 2026, announced on November 7, 2025, remain unchanged.